.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Poster

P252

Is the T1-w/T2-w putative myelin marker affected by iron deposition in globus pallidus, caudate, and normal appearing white matter in patients with secondary progressive multiple sclerosis?

Presented in

Clinical applications

Poster topics

Clinical applications

Authors

Stefan Gazdzinski (Warsaw, PL), Ewa Piątkowska-Janko (Warsaw, DE), Paweł Kazulo (Warsaw, DE), Kamil Lipiński (Warsaw, DE), Anna Karlińska (Warsaw, PL), Łukasz Smoliński (Warsaw, PL), Piotr Bogorodzki (Warsaw, DE), Paweł Grieb (Warsaw, PL), Mikołaj Pawlak (Poznań, PL), Rafał Rola (Warsaw, PL), Danuta Ryglewicz (Warsaw, PL), Iwona Kurkowska-Jastrzębska (Warsaw, PL)